Posttransplant Lymphoproliferative Disorder Case Presentation - PowerPoint PPT Presentation

1 / 21
About This Presentation
Title:

Posttransplant Lymphoproliferative Disorder Case Presentation

Description:

Post-transplant Lymphoproliferative Disorder - Case Presentation - Alison Jazwinski, MD ... Sent to FMC with persistently elevated liver enzymes on routine lab ... – PowerPoint PPT presentation

Number of Views:103
Avg rating:3.0/5.0
Slides: 22
Provided by: alisonja
Category:

less

Transcript and Presenter's Notes

Title: Posttransplant Lymphoproliferative Disorder Case Presentation


1
Post-transplant Lymphoproliferative Disorder -
Case Presentation -
  • Alison Jazwinski, MD
  • Flinders Medical Center
  • Adelaide, South Australia

2
Patient
  • 43 yo male
  • HPI
  • Sent to FMC with persistently elevated liver
    enzymes on routine lab check (ALT 971, AST 521)
  • On admission reported taking 2 Paracetamol
    tablets every 2 hours for a headache
  • Denied abdominal pain, melena/hematemesis,
    vomiting, diarrhea
  • Also denied numbness, weakness, difficultly
    swallowing or speaking

3
Patient
  • PMH
  • Protein C deficiency
  • Budd-Chiari Syndrome resulting in liver
    transplant 11/2007
  • Medications
  • Tacrolimus 7mg bid
  • Clonidine 100mg bid
  • Propanolol 40mg bid
  • Warfarin

4
Physical Exam
  • Vitals BP 130/78, HR 80, RR 16, temp 36.8
  • Gen well appearing male in NAD
  • HEENT no scleral icterus, MMM
  • Neck no lymphadenopathy
  • CV RRR no M/R/G
  • Lungs CTAB no W/R/R
  • Abdomen soft, mildly TTP RUQ, no
    rebound/guarding, NABS
  • Extrem no edema
  • Neuro CN II-XII intact, strength 5/5 all muscle
    groups, reflexes 2 throughout, gait normal,
    sensation intact to light touch, pinprick,
    vibration

5
Admission Labs
  • Na 141
  • K 4.0
  • Cl 105
  • Bicarb 25
  • Urea 6.2 (WNL)
  • Cr 103 (WNL)
  • Hb 127g/L
  • Hct 37
  • WBC 5.6
  • Platelets 108
  • Total prot 76g/L (WNL)
  • Albumin 43g/L (WNL)
  • Alk phos 165U/L
  • ALT 332U/L
  • AST 58U/L
  • Bili 14umol/L (WNL)
  • Paracetamol lt10
  • Tacrolimus 7.7

6
Patient
  • LFT abnormalities thought to be related to
    Paracetamol over-use.
  • He was using it for a headache why did he have a
    headache?
  • Further evaluation revealed

7
Head CT
8
Head CT
  • 28mm ring enhancing mass in right temporal lobe
    with moderate surrounding vasogenic edema. There
    is 6mm midline shift and effacement of overlying
    cerebral sulci.

9
Brain MRI
10
Brain MRI
  • Solitary, thick walled ring enhancing lesion in
    right temporal lobe measuring 2.8cm x 2.3 cm x
    1.8cm associated with extensive vasogenic edema
    and adjacent mass effect. Appearances are
    indeterminate, could represent a cerebral abscess
    however a high-grade glioma or solitary
    metastasis may also give this appearance.
  • When spectroscopy was added, the findings were
    keeping with a high grade primary cerebral
    neoplasm such as a GBM.

11
Differential Diagnosis
  • Infection
  • Bacterial abscess
  • Cryptococcus
  • Toxoplasma
  • Malignancy
  • Lymphoma
  • Primary CNS tumor
  • Metastatic disease

12
Further steps
  • Patient was initiated on dexamethasone and loaded
    with phenytoin for seizure proph
  • CT chest/abdomen/pelvis negative for source of
    primary malignancy
  • On to surgery with resection
  • Cultures sent for AFB, cryptococcus, toxoplasma,
    and bacterial culture, all returned negative

13
Histology
  • Features most in keeping with an EBV driven
    post-transplant lymphoproliferative disorder with
    no convincing monoclonality identified on
    immunoperoxidase stains and associated with
    considerable tissue necrosis

14
PTLD
  • Mostly large cell lymphomas
  • Most B cell type
  • Extranodal involvement in 30-70
  • Appears to be related to EBV inducing B cell
    proliferation in setting of chronic
    immunosuppression
  • PTLD cells are of host origin in the majority of
    cases

Transplantation 200681888 Transplantation
1990491080
15
Putative Checkpoints in the EBV Life Cycle That
Might Give Rise to Lymphoma
N Engl J Med 3501328, March 25, 2004
16
Forms of Disease
  • Benign polyclonal lymphoproliferation (55)
  • Infectious mono-type illness
  • Develops 2-8 weeks after immunosuppression
    initiated
  • Polyclonal B cell proliferation with normal
    cytogenetics
  • Polyclonal lymphoproliferation with early
    malignant transformation (30)
  • Localized solid tumors (15)
  • Monoclonal B cell proliferation with malignant
    cytogenetic abnormalities

Am J Pathol 1988 133173
17
Areas of Involvement
  • Gastrointestinal tract
  • Lungs
  • Skin
  • Liver
  • CNS (20-25)
  • Allograft lesions (20-25)

Transplantation 1995 59240
18
Treatment Approaches
  • Reduction in immunosuppression
  • Antiviral agents
  • Chemotherapy
  • Immune globulin
  • Surgical resection
  • Radiation
  • Interferon-alpha

Pediat Transplant 2001 5198
19
Reduction of Immunosuppression
  • Most will resolve with this
  • Best response among those with early disease
    where immunosuppression is a major contributing
    factor
  • Depends on severity of disease
  • Could reduce Prednisone to maintenance doses
    (7.5-10mg) and stop other agents
  • Could reduce Cyclosporine or Tacrolimus by 50
    and discontinue Azathioprine or MMF
  • Risk is allograft rejection

Transplantation 1999 681517
20
Other methods of treatment
  • Only case reports at this time
  • Largely dependent on severity of disease and
    treatment center

21
Thanks!
Write a Comment
User Comments (0)
About PowerShow.com